Key facts
- This page summarizes John P. Francis's Form 4 filing for Catheter Precision, Inc. (VTAK).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 10 Jan 2024, 16:31.
John P. Francis - 08 Jan 2024 Form 4 Insider Report for Catheter Precision, Inc. (VTAK)
- Reporting relationship
- Director
- Issuer ticker
- VTAK
- Reported as of
- 08 Jan 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 10 Jan 2024, 16:31:32 UTC
- Prior SEC filing
- 10 Jan 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ John P. Francis
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
John P. Francis filed Form 4 for Catheter Precision, Inc. (VTAK) on 10 Jan 2024.
Change
- Previous filing in this sequence was filed on 10 Jan 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
VTAK
transaction
Derivative
Options (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +25,000
- Change %
- Price
- $0.000000
- Shares after
- 25,000
- Date
- 08 Jan 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 25,000
- Exercise price
- $0.4000
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Options vests 8 1/3% every three months beginning on April 8, 2024.